Tech & Innovation
[Press release – not published yet] Moderna’s COVID-19 vaccine candidate shows 94.5% protection in an interim analysis of the phase 3 COVE study
17 Nov, 2020 | 09:55h | UTCPress release: Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study
See also: Moderna Announces Longer Shelf Life for its COVID-19 Vaccine Candidate at Refrigerated Temperatures
Commentaries: What Moderna’s Covid-19 vaccine results mean for ending the pandemic – Vox AND Moderna follows Pfizer with exciting vaccine news – how to read these dramatic developments – The Conversation AND Moderna’s COVID Vaccine Is 95% Effective – Independent NIH-Appointed Board Assessment – Higher Storage Temperature Make It Even Better News – Health Policy Watch AND Moderna’s Vaccine News “Encouraging” But Won’t Solve Immediate Problem of Virus Surge in Europe & Americas – WHO – Health Policy Watch AND COVID vaccine excitement builds as Moderna reports third positive result – Nature AND Moderna’s Covid-19 vaccine is strongly effective, early look at data show – STAT AND With strong data on two Covid-19 vaccines, we have more answers about the road ahead — and questions too – STAT AND Early data show Moderna’s COVID vaccine 94.5% effective – CIDRAP AND A Note Of Caution On Moderna’s Promising Covid-19 Vaccine News – Forbes AND Promising Interim Results from Clinical Trial of NIH-Moderna COVID-19 Vaccine – NIH News Releases AND Moderna: Covid vaccine shows nearly 95% protection – BBC AND Latest vaccine success is good news but high price may restrict access – The Guardian AND ‘Just beautiful’—Another COVID-19 vaccine, from newcomer Moderna, succeeds in large-scale trial – Science AND Moderna trial success gives world more hope in race to end pandemic – Reuters AND Expert reaction to Moderna announcement of its phase 3 vaccine interim results – Science Media Centre
[Abstract Only] Study: An automated predictive model can identify hospitalized adults outside the ICU at risk for clinical deterioration for whom interventions by rapid-response teams could be implemented
13 Nov, 2020 | 09:16h | UTCAutomated Identification of Adults at Risk for In-Hospital Clinical Deterioration – New England Journal of Medicine (link to abstract – $ for full-text)
Perspective: Reinventing pediatrics through video care first
3 Nov, 2020 | 02:57h | UTCReinventing Pediatrics Through Video Care First – JAMA Pediatrics (free for a limited period)
Video consultations in primary and specialist care during the covid-19 pandemic and beyond
21 Oct, 2020 | 09:30h | UTCVideo consultations in primary and specialist care during the covid-19 pandemic and beyond – The BMJ
The end of dengue fever? Mosquito experiment in Indonesia sees huge reduction in cases
13 Oct, 2020 | 00:59h | UTC
New test detects coronavirus in just 5 minutes
12 Oct, 2020 | 00:39h | UTCNew test detects coronavirus in just 5 minutes – Science
Comparison of chest radiograph interpretations by artificial intelligence algorithm vs. radiology residents
12 Oct, 2020 | 00:27h | UTC
Commentary on Twitter
Diagnostic study finds an #AI algorithm has similar sensitivity with improved specificity and positive predictive value vs radiology residents when reading AP chest x-rays. https://t.co/SBUaZTz6OC
— JAMA Network Open (@JAMANetworkOpen) October 10, 2020
The use of mobile phone data to inform analysis of COVID-19 pandemic epidemiology
4 Oct, 2020 | 23:26h | UTCThe use of mobile phone data to inform analysis of COVID-19 pandemic epidemiology – Nature
Commentary on Twitter
In this Perspective, @khgrantz, @hanmered, @datcummings, @CJEMetcalf, @GilesJohnR, @shrutihmehta, @sss_cubed, @alabriqu, @nish_epi, @Caroline_OF_B, @apwez review the different applications for mobile phone data to support the COVID-19 pandemic responsehttps://t.co/tvmRlYcMww
— Nature Communications (@NatureComms) October 2, 2020
Review: Artificial intelligence in COVID-19 drug repurposing
22 Sep, 2020 | 09:36h | UTCArtificial intelligence in COVID-19 drug repurposing – The Lancet Digital Health
Welcoming new guidelines for AI clinical research
10 Sep, 2020 | 09:23h | UTCWelcoming new guidelines for AI clinical research – Nature Medicine
Guidelines: Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension – Nature Medicine AND Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension – Nature Medicine
Commentary on Twitter
Today's a very big day fo #AI medical research
There are major publications of consensus statements and guidelines published @NatureMedicine @LancetDigitalH @bmj_latest on protocols, trial design, and reporting
Here's my commentary @NatureMedicine https://t.co/86b8WxjX0Q pic.twitter.com/PwYPF7o4qn— Eric Topol (@EricTopol) September 9, 2020
COVID-19 and mRNA vaccines—first large test for a new approach
4 Sep, 2020 | 02:08h | UTCCOVID-19 and mRNA Vaccines—First Large Test for a New Approach – JAMA
[Abstract Only] Randomized trial: Closed-loop control in children with type 1 diabetes
27 Aug, 2020 | 09:45h | UTCCommentary: Artificial pancreas effectively controls type 1 diabetes in children age 6 and up – NIH News Releases
Systematic review: Automated and partly automated contact tracing to control COVID-19
21 Aug, 2020 | 02:32h | UTCCommentary: Contact tracing apps unlikely to contain COVID-19 spread – University College London
Digital contact tracing technologies in epidemics: a rapid review
19 Aug, 2020 | 09:36h | UTCDigital contact tracing technologies in epidemics: a rapid review – Cochrane Library
Commentary: Featured Review: Digital contact tracing technologies in epidemics: a rapid review – Cochrane Library
Perspective: Digital public health and COVID-19
13 Aug, 2020 | 00:19h | UTCDigital public health and COVID-19 – The Lancet Public Health
Randomized trial: Robotic vs. laparoscopic ventral hernia repair
31 Jul, 2020 | 08:35h | UTCCommentary: #VisualAbstract: Robotic vs. laparoscopic ventral hernia repair – 2 Minute Medicine
Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs. other neurodegenerative disorders
29 Jul, 2020 | 09:29h | UTCDiscriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders – JAMA (free for a limited period)
Non-invasive early detection of cancer four years before conventional diagnosis using a blood test
27 Jul, 2020 | 09:37h | UTC
Coronavirus sparks new interest in using ultraviolet light to disinfect indoor air
15 Jul, 2020 | 08:26h | UTCCoronavirus Sparks New Interest In Using Ultraviolet Light To Disinfect Indoor Air – NPR
Researchers develop COVID-19 mortality risk calculator
14 Jul, 2020 | 08:33h | UTCResearchers develop COVID-19 mortality risk calculator – News Medical
Original Study [Preprint]: COVID-19 Mortality Risk Assessment: An International Multi-Center Study – medRxiv
See Calculator: COVID Analytics
Related Commentary on Twitter
Our team developed and validated a new COVID-19 mortality risk score using data from 33 hospitals across four different countries. I am very proud of this international collaboration. The paper is now available on medrxiv: https://t.co/VGEPJYqbEf
— Agni Orfanoudaki (@AgniOrfanoudaki) July 10, 2020
Meta-Analysis: Electronically Delivered vs. Face to Face Cognitive Behavioral Therapies in Depressive Disorders
2 Jul, 2020 | 08:35h | UTC
Study: An Electronic Decision Support Tool Can Safely Reduce Polypharmacy in Elderly People
24 Jun, 2020 | 03:23h | UTCCommentary: Reduction of polypharmacy by electronic decision support—less is more – The BMJ Opinion
Transplantation of Discarded Livers Following Viability Testing with Normothermic Machine Perfusion
24 Jun, 2020 | 03:17h | UTCCommentary: Liver perfusion could save 7 in 10 rejected donor livers – University of Birmingham
Ethical Guidelines for COVID-19 Tracing Apps
29 May, 2020 | 03:18h | UTCEthical guidelines for COVID-19 tracing apps – Nature
A Deep Learning Algorithm to Detect Chronic Kidney Disease from Retinal Photographs
29 May, 2020 | 03:02h | UTC
Related Commentary on Twitter
A deep learning algorithm to detect chronic #KidneyDisease from retinal photographs in community-based populations @LancetDigitalH👉https://t.co/Q4J4LXe9nX pic.twitter.com/J2vA4shtZQ
— The Lancet Reg Health-West Pacific (@LancetRH_WPac) May 20, 2020